Muattaz Hussain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muattaz Hussain has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ankita Borah
1 shared publication- Burcu Binici
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK
1 shared publication Filia Stephanie
1 shared publication- Geoff Coxon1 shared publication
- Hakam Alaqabani
Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, University of Strathclyde, Glasgow G4 0RE, UK; Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Airport St, 11733 Amman, Jordan
1 shared publication John Parkinson
1 shared publication
Latest Publications
- 18 October 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 706
IVIS assessment of mRNA-LNP protein expression: effects of dosing parameters and prior LNP exposure
- 18 October 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 706
IVIS assessment of mRNA-LNP protein expression: effects of dosing parameters and prior LNP exposure
- Open Access
- 8 September 2026
- Published by Elsevier in SSRN Electronic Journal
Structure–Function Relationships of Ionisable Lipids: Headgroup-Driven Changes in Lipid Nanoparticle Architecture and mRNA Delivery Outcomes
Ionisable lipids are key functional components of lipid nanoparticles (LNPs), with molecular structure influencing nanoparticle properties and mRNA delivery. This study investigated the effects of headgroup hydroxyl functionality and linker length on the physicochemical properties, ionisation behaviour and biological performance of ALC-0315 and SM-102 derived ionisable lipids. Sixteen hydroxylated lipids, and corresponding methylated analogues, were synthesised and formulated into firefly luciferase mRNA-loaded LNPs. These were characterised for size, polydispersity, zeta potential, encapsulation efficiency, apparent pKa and lipid organisation using quantitative 1H NMR, followed by in vitro and in vivo evaluation of mRNA delivery.All formulations formed nanoscale, low polydispersity particles with near neutral surface charge, indicating that headgroup modification did not prevent LNP assembly. Hydroxylated lipids exhibited apparent pKa values within the range 6.30–6.57 and produced greater luciferase expression in vitro and in vivo than methylated analogues. Methylation typically reduced apparent pKa and transfection efficiency without substantially affecting particle size, encapsulation or cell viability, suggesting impaired intracellular delivery. Quantitative 1H NMR indicated that hydroxylation also influenced lipid organisation and surface accessibility. Notably, methyl analogue, heptadecan-9-yl 8-((5-methoxypentyl)(6-oxo-6-(undecyloxy)hexyl)amino)octanoate (FS-22), retained substantial in vivo activity, demonstrating that delivery performance depends on overall ionisable lipid architecture rather than hydroxyl functionality alone.
- 8 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessStructure–Function Relationships of Ionisable Lipids: Headgroup-Driven Changes in Lipid Nanoparticle Architecture and mRNA Delivery Outcomes
Ionisable lipids are key functional components of lipid nanoparticles (LNPs), with molecular structure influencing nanoparticle properties and mRNA delivery. This study investigated the effects of headgroup hydroxyl functionality and linker length on the physicochemical properties, ionisation behaviour and biological performance of ALC-0315 and SM-102 derived ionisable lipids. Sixteen hydroxylated lipids, and corresponding methylated analogues, were synthesised and formulated into firefly luciferase mRNA-loaded LNPs. These were characterised for size, polydispersity, zeta potential, encapsulation efficiency, apparent pKa and lipid organisation using quantitative 1H NMR, followed by in vitro and in vivo evaluation of mRNA delivery.All formulations formed nanoscale, low polydispersity particles with near neutral surface charge, indicating that headgroup modification did not prevent LNP assembly. Hydroxylated lipids exhibited apparent pKa values within the range 6.30–6.57 and produced greater luciferase expression in vitro and in vivo than methylated analogues. Methylation typically reduced apparent pKa and transfection efficiency without substantially affecting particle size, encapsulation or cell viability, suggesting impaired intracellular delivery. Quantitative 1H NMR indicated that hydroxylation also influenced lipid organisation and surface accessibility. Notably, methyl analogue, heptadecan-9-yl 8-((5-methoxypentyl)(6-oxo-6-(undecyloxy)hexyl)amino)octanoate (FS-22), retained substantial in vivo activity, demonstrating that delivery performance depends on overall ionisable lipid architecture rather than hydroxyl functionality alone.
- Open Access
- 25 February 2026
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 223, 115034
Incorporating immunostimulatory lipids into lipid nanoparticles: exploring expression and immune responses
- 25 February 2026
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 223, 115034
Open AccessIncorporating immunostimulatory lipids into lipid nanoparticles: exploring expression and immune responses